Hong‐Shuai Li

Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations

Guangjian Yang, Jun Li, Haiyan Xu et al. · Lung Cancer · 2020 · 50 citations

Insertion Mutations, Diverse Egfr, Medicine +7

α-2,8-sialyltransferase is involved in the development of multidrug resistance via PI3K/Akt pathway in human chronic myeloid leukemia

Xu Zhang, Weijie Dong, Huimin Zhou et al. · IUBMB Life · 2015 · 46 citations · Full text

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review

Hong‐Shuai Li, Siyu Lei, Junling Li et al. · Frontiers in Immunology · 2022 · 32 citations · Full text

SHIP1 inhibits cell growth, migration, and invasion in non‑small cell lung cancer through the PI3K/AKT pathway

Qiaofen Fu, Yuhui Huang, Chunlei Ge et al. · Oncology Reports · 2019 · 20 citations · Full text

Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study)

Hong‐Shuai Li, Shouzheng Wang, Haiyan Xu et al. · Cancers · 2022 · 18 citations · Full text